The oncogenic nature of SLC3A2, demonstrated via both in vitro and in vivo studies, aligns with our bioinformatics findings, highlighting the critical function of SLC3A2 in the development of glioma. The gene discussed is SLC3A2; the disease is central nervous system cancer.